Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach

[1]  M. Yoneda,et al.  High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy , 2007, Journal of Neuroimmunology.

[2]  F. Ferracci,et al.  The neurological disorder associated with thyroid autoimmunity , 2006, Journal of Neurology.

[3]  B. Boeve,et al.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis. , 2006, Archives of neurology.

[4]  E. Bargagli,et al.  Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis , 2005, Proteomics.

[5]  T. Hashimoto,et al.  Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients , 2004, Journal of the Neurological Sciences.

[6]  C. Hess,et al.  Encephalopathy associated with Hashimoto thyroiditis: Diagnosis and treatment , 1996, Journal of Neurology.

[7]  G. Moretto,et al.  Antithyroid antibodies in the CSF , 2003, Neurology.

[8]  H. Saya,et al.  Proteomic analysis of human brain identifies α‐enolase as a novel autoantigen in Hashimoto's encephalopathy , 2002 .

[9]  S. Bombardieri,et al.  The targets of nephritogenic antibodies in systemic autoimmune disorders. , 2002, Autoimmunity reviews.

[10]  G. Moretto,et al.  Enhanced Expression of NGF Receptors in Multiple Sclerosis Lesions , 2002, Journal of neuropathology and experimental neurology.

[11]  M. Schnölzer,et al.  A new silver staining apparatus and procedure for matrix‐assisted laser desorption/ionization‐time of flight analysis of proteins after two‐dimensional electrophoresis , 2001, Proteomics.

[12]  T. Montine,et al.  Expression and Activities of Aldo‐Keto Oxidoreductases in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[13]  D. Harrison,et al.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. , 1999, The Biochemical journal.

[14]  Ian G. Charles,et al.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. , 1999, The Biochemical journal.

[15]  F Gharahdaghi,et al.  Mass spectrometric identification of proteins from silver‐stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity , 1999, Electrophoresis.

[16]  R J Mark,et al.  Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation , 1997, The Journal of Neuroscience.

[17]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[18]  P. Vallance,et al.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase , 1996, British journal of pharmacology.

[19]  U. Hellman,et al.  Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. , 1995, Analytical biochemistry.

[20]  D. Petersen,et al.  The oxidation of α-β unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases☆ , 1987 .

[21]  L. Brain,et al.  Hashimoto's disease and encephalopathy. , 1966, Lancet.